Aimco Pesticides

- The company plans to fund its current expansion entirely through internal accruals, with no intention for further borrowing as per the discussion with Milan Shah. - Current total debt stands at about ₹7 crore, with a plan to significantly reduce it by March. - No mention or indication of any future equity fundraising in the transcript. - The focus remains on reducing existing debt and utilizing internal funds for growth and capacity expansion.

- Aimco Pesticides is planning a capacity expansion with an estimated CAPEX of around ₹10 crore. - This expansion includes manufacturing capacity as well as utility improvements. - The new capacity is expected to boost production from the current 350 tons per month to 500 tons per month by June or July next year. - Post this expansion, the company anticipates an annual turnover increase of approximately ₹100-150 crore. - Beyond the current expansion, there is a plan for one more expansion to produce a new molecule. - For growth beyond these, the company will need to consider setting up a new manufacturing site, anticipated around two to two and a half years from now. - The expansion will be funded through internal accruals without any additional borrowings.

- Aimco Pesticides plans to grow about 20% annually by increasing current capacity with existing products and adding new molecules in the next 3-5 years. - Two new niche molecules with high margin potential are being registered and expected to commercialize in 3-5 years. - Expansion underway to increase production capacity from ~350 tons/month to 500 tons/month by June-July next year, which should add ₹100-150 crore turnover annually. - Contract manufacturing business is stabilizing around ₹22-23 crore per quarter with plans to increase volumes via capacity expansion. - Export sales currently ~50% of turnover, expected to grow further with new molecules focused more on exports. - Branded formulation business will be grown cautiously and without aggressive expansion. - Overall, confident of steady sales with seasonal variation and expectation of improved profitability from Q3 onwards.

- Aimco Pesticides targets around 20% annual growth by expanding current capacity and introducing two new niche, high-margin molecules within 3-5 years. - New molecules focus on export markets and are expected to contribute significantly to sales and margins. - Current EBITDA margins are improving, with expectations to reach double-digit operating margins soon, once price stabilization occurs. - Contract manufacturing expansion planned, with CAPEX of ~₹10 crore, expected to add ₹100-150 crore turnover per year from increased capacity. - Margins expected to improve from Q3 onwards as cost pass-through mechanisms mature. - Cautious growth in B2C branded formulation segment; main focus remains on B2B manufacturing with higher margins. - Debt reduction underway, which should positively impact profitability. - Overall, the company expects more stable and higher profitability, driven by capacity ramp-up, new products, and better pricing power.

- Current order book volume supports a quarterly revenue run rate of around ₹80 crores, aiming for an annual turnover close to ₹350 crores. - Contract manufacturing sales have ramped up significantly, contributing about ₹20 crores in Q2, expected to stabilize at ₹22-23 crores per quarter onwards. - Discussions are ongoing to increase contract manufacturing quantities, with capacity expansion work starting in December and expected to complete by June/July next year. - New molecule registrations are in progress, with expectations of receiving at least one product registration this financial year, although no concrete updates yet. - Expansion plans include adding capacity to increase production from the current 350 tons/month to 500 tons/month by June/July next year, supporting higher order fulfillment. - The company is confident of maintaining and increasing sales volumes, contingent on external factors like monsoon and global conditions.